Mustang Bio Inc logo

Mustang Bio Inc

NAS:MBIO (USA)  
$ 0.36 -0.0047 (-1.31%) 03:10 PM EST
At Loss
P/B:
35.50
Enterprise V:
$ -202.00K
Volume:
71.65K
Avg Vol (2M):
301.16K
Also Trade In:
Volume:
71.65K
At Loss
Avg Vol (2M):
301.16K

Business Description

Description
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 2.5
Equity-to-Asset 0.01
Debt-to-Equity 20.31
Debt-to-EBITDA -0.05
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.92
9-Day RSI 22.07
14-Day RSI 23.37
6-1 Month Momentum % -35.71
12-1 Month Momentum % -74.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.74
Quick Ratio 0.74
Cash Ratio 0.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.4
Shareholder Yield % 575.87
Name Current Vs Industry Vs History
ROE % -274.67
ROA % -110.53
ROIC % -408.92
ROC (Joel Greenblatt) % -640.71
ROCE % -154.03

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 35.5
Price-to-Tangible-Book 35.5
EV-to-Forward-EBIT -0.23
EV-to-Forward-EBITDA -0.23
FCF Yield % -1341.93

Financials (Next Earnings Date:2024-05-10 Est.)

MBIO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MBIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Mustang Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -6
Beta 1.61
Volatility % 80.82
14-Day RSI 23.37
14-Day ATR ($) 0.097485
20-Day SMA ($) 0.64077
12-1 Month Momentum % -74.53
52-Week Range ($) 0.33 - 8.17
Shares Outstanding (Mil) 10.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mustang Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Mustang Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Mustang Bio Inc Frequently Asked Questions

What is Mustang Bio Inc(MBIO)'s stock price today?
The current price of MBIO is $0.36. The 52 week high of MBIO is $8.17 and 52 week low is $0.33.
When is next earnings date of Mustang Bio Inc(MBIO)?
The next earnings date of Mustang Bio Inc(MBIO) is 2024-05-10 Est..
Does Mustang Bio Inc(MBIO) pay dividends? If so, how much?
Mustang Bio Inc(MBIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1